Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Equipment >

SpectraSCIENCE, Inc. (SCIE)

Add SCIE Price Alert      Hide Sticky   Hide Intro
Moderator: XenaLives, flipquick249, MVIR, PennystockID2017, Pugilista, Dragnet
Search This Board: 
Last Post: 10/20/2017 5:43:27 PM - Followers: 262 - Board type: Free - Posts Today: 7

Spectra Science - Innovations In Cancer Detection

SCIE Will Begin meeting with the FDA towards the preparation and submission of a Supplemental PMA filing with the FDA and plan for additional clinical trials to support eventual approval for sale in the United States !!
Lighting the way to improve your practice.

The proprietary WavSTAT Optical Biopsy System assists the practicing gastroenterologist who uses a flexible endoscope to find polyps that may be cancerous. The capability to distinguish if the tissue is cancerous or not is made immediately, and complements your expertise. The physician uses laser-induced fluorescence and an optical fiber to transmit laser light via the flexible endoscope to the tissue. The auto-fluorescence from the tissue is then collected and returned to an optical detector for analysis. The result is then available with no waiting days for a pathology report.

Simply stated, we work with you to create better outcomes for your patients.

Our value proposition is simple

We improve a doctor's ability to diagnose cancer
and we lower the cost of diagnosis.

SpectraScience offers a simplified yet highly effective way of diagnosing colorectal cancer early, when recovery rates are high. Our WavSTAT Optical Biopsy System® uses light to diagnose tissue health. In fact, our patented technology instantly detects if tissue is normal, pre-cancerous or cancerous without the need for a costly physical biopsy.

According to the American Cancer Society, over 140,000 new cases of colorectal cancer are expected in the US this year alone. This dreaded disease is the second leading cause of cancer-related deaths in the US (after lung cancer), and the third most common cancer overall. Only 39% of colorectal cancers are detected at an early stage.


Our proprietary WavSTAT Optical Biopsy System is used as an adjunct to the gastroenterologist in normal practice and is compatible with existing endoscopes. The WavSTAT uses Laser Induced Fluorescence and an optical fiber forceps to transmit laser light via endoscope to the tissue. Auto-fluorescence back from the interrogated tissue is collected and returned to an optical detector for analysis and a definitive diagnostic rendered. The WavSTAT provides a binary, "Suspect" or "Non-Suspect" diagnostic output which, unlike traditional image-based systems, requires no analysis or interpretation.


Laser-Induced Fluorescence Spectroscopy (LIF)

The WavSTAT Optical Biopsy System is presently based upon technology that detects the native fluorescence of tissue. Fluorescence occurs when various molecular components present in tissue are “excited” at certain wavelengths of light and re-emit energy in a distinct and measurable way. This re-emitted energy is referred to as the spectral signature. Healthy tissue generates a spectral signature that is measurably different from tissue that is not normal, such as cancerous and pre-cancerous tissue. LIF targets these chemical properties of tissue: amino acids, enzymes, and structural proteins.

Scattering Spectroscopy (SS)

This IP-protected technology is a novel optical scientific method that will complement our LIF technology in future WavSTAT Systems. It can be used in combination with LIF or stand-alone for diagnosis. SS targets physical properties of tissue: vascularity, epithelial thickness and cell nuclei.

SS employs a wavelength-dependent component of light scattered by epithelial cells to obtain information about subcellular structures, such as cell nuclei. Since nuclear atypia is one of the hallmarks of precancerous and cancerous changes in most human tissues, the technique has the potential to provide a broadly applicable means of detecting epithelial precancerous lesions and noninvasive cancers in various organs*. These can be optically accessed either directly or by means of optical fibers. Therefore, SS facilitates the ability to scan the tissue and detect, not merely diagnose, possible cancerous lesions.
*Citable URI:

Multi Modal

In the future, we envision a combination of LIF and SS will provide a blend of light-based diagnoses for optimal clinical results across many different kinds of cancer. We believe that this “multi-modal” future will allow us to pursue many detection and diagnosis markets, with an increased number of possible strat

The WavSTAT mobile console is the heart of the system and is comprised of a low-power laser, a sophisticated light detector, an internal computer and analysis software. The console incorporates a touch screen for input and output as well as the capability of interfacing with additional screens providing, for example, an image which can be included on a typical endoscope monitor. The key to the diagnostic process is our proprietary waveform analysis algorithm. used today to diagnose colon cancer and precancerous tissue.

SpectraScience, Inc

Most Recent Financials

Filed Date Form Type Description View
05/22/2017 Form 10-Q Quarterly report
05/15/2017 Form NT 10-Q Notification of inability to timely Form 10-Q
    Partial List of Company Owned PATENTS:
Referenced by
Citing Patent Filing date Publication date Applicant Title
WO1999045838A1 * Mar 9, 1999 Sep 16, 1999 Spectrascience, Inc. Optical biopsy system and methods for tissue diagnosis
EP2018824A1 * Mar 9, 1999 Jan 28, 2009 Spectrascience, Inc. Optisches Biopsiesystem und Verfahren zur Gewebediagnose
US6066102 * Mar 9, 1998 May 23, 2000 Spectrascience, Inc. Optical biopsy forceps system and method of diagnosing tissue
US6174291 * Mar 9, 1998 Jan 16, 2001 Spectrascience, Inc. Optical biopsy system and methods for tissue diagnosis


You are here: about / management


Michael P. Oliver     President and Chief Executive Officer

Mr. Oliver, has more than 20 years of experience in the medical device industry, and has been a member of four separate management teams that took over struggling medical device companies, increased their revenues and profitability and sold them to strategic buyers. In these companies Mr. Oliver served in the capacity of head of sales and marketing, and, in two cases held major operational responsibilities as well. Mr. Oliver received his MSA from George Washington University and his BS from the United States Naval Academy.

Lowell Giffhorn     Chief Financial Officer

Lowell Giffhorn, CFO, joined the Company in September 2013.  Mr. Giffhorn brings to the Company more than 20 years of senior management experience in finance, operations, planning and and strategic planning. Prior to joining SpectraScience, Mr. Giffhorn was Chief Financial Officer of Patriot Scientific and Sym-Tek systems, both micro-cap public companies.  He was instrumental in helping to raise more than $20 million in public equity.  Mr. Giffhorn practiced as a Certified Public Accountant with Arthur Young (Ernst and Young) and holds an MBA and a BS in Accounting from the University of Illinois.

Hughes Wielemans     Director of Business Development - Europe

Mr. Wielemans has over 20 years of experience in sales, marketing and management while working for multi-national medical device companies and distributors in Europe.Most recently, he was the Director of Sales and Marketing for USGI Medical, Ltd. in Europe. Prior to this he was the Country Manager for Bariatric Solutions Gmbh in Belgium. Mr. Wielemans spent three years as the Director of Sales & Marketing for Covidien Belgium. Before this he worked as European Product Director and Manager for six years with Tyco Healthcare. Mr. Wielemans attended the Institut Catholique des Hautes Etudes Commerciales, Brussels, Sciences Economiques. 

Mike Brady      Director of Engineering

Most recently Mr. Brady spent three years as a Senior Project Manager/ Systems Engineer. Prior to this he spent three years at Elgar Electronics where he managed several concurrent engineering projects. Before this, Mr. Brady spent thirteen years at leading medical device manufacturer Mallinckrodt/Nellcor Puritan Bennet, where he was a Senior Project Manger/Principal Electronic Engineer. Brady holds a BSEE degree from San Diego State University.

Todd Pinkowski     Director of Operations

Mr. Pinkowski brings over 23 years of extensive operations and production experience to the Company. Prior to SpectraScience, Inc. Mr. Pinkowski spent nine years with ResMed Corp. as Senior Manager of Technical Service and Manufacturing. Before this he spent 14 years as a Senior Production Supervisor with Infrasonics/Nellcor PB. Mr. Pinkowski began his career as an Aircraft Armament Systems Specialist with the U.S. Air Force.


Wells Fargo Shareholder Services (Minneapolis, MN) 

Transfer Agent 
1110 Centre Pointe Curve
Suite 101
St. Paul, MN 55120
SCIE Security Details
Share Structure
  Market Value1 $432,096 a/o Jul 21, 2017
  Authorized Shares 6 Billion
  Outstanding Shares 2,685,830,579. August 14, 2017
  -Restricted Not Available
  -Unrestricted Not Available
  Held at DTC Not Available
  Float Not Available
  Par Value 0.01

  • 11568 Sorrento Valley Rd # 11
    San Diego, CA 92121
    Telephone: 858-847-0200
    Directions: Click
Update with SpectraScience, Inc.- Medical Device Company Discusses 2016 Corporate Developments

Interactive Brokers Advertisement
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SCIE News: Quarterly Report (10-q) 08/14/2017 02:59:53 PM
SCIE News: Information Statement - All Other (definitive) (def 14c) 08/11/2017 01:17:26 PM
SCIE News: Proxy Statement - Other Information (preliminary) (pre 14c) 07/31/2017 05:04:15 PM
SCIE News: Quarterly Report (10-q) 05/22/2017 03:36:11 PM
SCIE News: Notification That Quarterly Report Will Be Submitted Late (nt 10-q) 05/15/2017 03:06:48 PM
#23373  Sticky Note Thanks stervc, yankee2 for Your excellent DD. Following MVIR 10/15/17 07:13:11 PM
#22148  Sticky Note Minnesota Sec of State shows 5 billion AS Dragnet 09/15/17 08:32:02 PM
#10802  Sticky Note Must Read: XenaLives 04/25/16 02:10:18 PM
#23510   That'a an amazing indication of what to expect $kytrader 10/20/17 05:43:27 PM
#23509   80 mill buys. Good slide Friday.... jablome 10/20/17 05:17:10 PM
#23508   Wow! wedman 10/20/17 04:09:24 PM
#23507   Nice 66mil+ ask slap! SCIE! 10miljoen 10/20/17 03:53:59 PM
#23506   $SCIE lets gooo MrDinero 10/20/17 03:51:25 PM
#23505   Bid are getting bigger rmbarcelo 10/20/17 09:34:55 AM
#23504   3$ on deck jablome 10/20/17 09:31:06 AM
#23503   Chart is predicting a price explosion here, I Chartmaster 10/19/17 10:19:04 PM
#23502   Loading continues! Incredible. wolfjr 10/19/17 04:32:39 PM
#23501   Interesting read! wolfjr 10/19/17 12:56:12 PM
#23500   LMFAO working hard for dem 1's ... DUMBMONEY 10/19/17 12:25:53 PM
#23499   Endless 2,s uff lets goo $SCIE MrDinero 10/19/17 11:21:55 AM
#23498   Lol go go go go go Evandean1 10/19/17 10:16:46 AM
#23497   Some news out today. This is showing wedman 10/19/17 09:51:51 AM
#23496   18M in the firts 5 min rmbarcelo 10/19/17 09:39:13 AM
#23495   115m buys VS 5m sells. Huge loading today. wolfjr 10/18/17 05:22:03 PM
#23494   I remember the first time I picked up jablome 10/18/17 05:20:56 PM
#23491   $SCIE 2's will fall soon MrDinero 10/18/17 11:24:13 AM
#23490   $SCIE$ has the largest patent portfolio on optical Nasdak2012 10/18/17 10:56:32 AM
#23489   SCIE WavSTAT System IS NOT Saving Lives in XenaLives 10/18/17 10:19:55 AM
#23488   As long as it's saving lives. jablome 10/18/17 09:29:22 AM
#23487   Anyone who invests in this company should look XenaLives 10/18/17 07:33:54 AM
#23486   Slide six of presentation for IP's... jablome 10/18/17 05:46:31 AM
#23485   Link to patents please... XenaLives 10/18/17 01:43:11 AM
#23484   LINK please... XenaLives 10/18/17 01:42:23 AM
#23483   Got a peer reviewed paper on that? XenaLives 10/18/17 01:41:23 AM
#23482   We're dive-n in.... jablome 10/17/17 09:02:43 PM
#23480 jablome 10/17/17 08:52:52 PM
#23479   96.9%_accuracy.This is a winner,I love saving lives.. jablome 10/17/17 08:46:20 PM
#23478   38 IP's looking good.. jablome 10/17/17 08:43:10 PM
#23477   Recent IP license from Duke University. jablome 10/17/17 08:40:00 PM
#23476   I like slide shows, yaaa... jablome 10/17/17 08:35:34 PM
#23475   Titan Medical Appoints Perry A. Genova Vice President torenzial 10/17/17 07:46:01 PM
#23474   I WAS DIGGING YESTERDAY.. IT FELT LIKE I torenzial 10/17/17 07:43:54 PM
#23472   Looks like insider buying while some are selling KNTN 10/17/17 06:33:35 PM
#23471   Except they have NO patents and NO money. CashMoney75 10/17/17 05:57:12 PM
#23470   Monday someone posted a link for Oncoscope as wanna be 10/17/17 05:33:07 PM
#23469   30_mins_up_no_T_trades.Not to bad 2.5 bill on the buy.... jablome 10/17/17 04:34:31 PM
#23468   I'll be loading more 2's tomorrow..great things ahead $SCIE MrDinero 10/17/17 04:26:40 PM
#23467   127 million buys today says something. jablome 10/17/17 04:08:48 PM
#23466   Ya bigger picture..... KNTN 10/17/17 02:05:33 PM
#23465   They can be quit expensive:)..... jablome 10/17/17 01:29:21 PM
#23464   Back to .0001 maybe those forceps can pull Pugilista 10/17/17 01:14:33 PM
#23463   FDA APPROVAL WITH DUMPAGE IN PROGRESS LOL Opinionator 10/17/17 12:52:12 PM
#23462   bid over 2B says it all. Dont see MIKEY501 10/17/17 12:47:55 PM
#23461   Broke? Heck with 5 billion shares sold..maybe Dragnet 10/17/17 12:10:30 PM
#23460   Another 23M slap of the ask $kytrader 10/17/17 11:07:05 AM
#23459   Old crap OUCH!!! 23M slap of the ask weeeeee. $kytrader 10/17/17 11:06:36 AM
#23457   Ouch! Trials needed for FDA and they XenaLives 10/17/17 10:33:11 AM
#23456   Ooops - Pentax is no longer promoting them. XenaLives 10/17/17 10:31:34 AM